NewsBenzingaTwinStrand Biosciences Announces U.S. Patent And Trademark Office's Patent Trial And Appeal Board Rejects Guardant Health's Challenge To Core Patent Underlying Duplex Sequencing TwinStrand Biosciences Announces U.S. Patent And Trademark Office's Patent Trial And Appeal Board Rejects Guardant Health's Challenge To Core Patent Underlying Duplex Sequencing Benzinga 2026.10.15 20:03 (GMT+0) Open on Benzinga Other news US Judge Orders Meta to Pay $25 Billion Fine to New Mexico JP Morgan Maintains Overweight on SpaceX, Raises Price Target to $500 Keefe, Bruyette & Woods Maintains Outperform on Dime Commercial, Raises Price Target to $49 Keefe, Bruyette & Woods Maintains Outperform on AppFolio, Raises Price Target to $255 BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125 JP Morgan Maintains Neutral on Corning, Lowers Price Target to $165
